HGEN: 4 hour chart at end of February 2021关于NASDAQ:HGEN由decaro提供

Mid-March presentations of trial results are imminent. Price targets between $30 and $34 have been set. Today, RSI is testing a level that has recently held.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。